INTUITIVE SURGICAL INC Annual Report, Year Ended Dec 31, 2023

Intuitive Surgical Inc. (ISRG) demonstrated robust financial performance in its 2023 fiscal year, reporting a 14% increase in total revenue to $7.1 billion. This growth was primarily driven by a strong 22% increase in instruments and accessories revenue, reflecting higher da Vinci procedure volumes, which rose 22% to approximately 2.3 million procedures. The company also saw a significant 129% surge in Ion procedures. Despite flat systems revenue, the installed base of da Vinci systems grew by 14% to 8,606 units, indicating continued market penetration and utilization. The company's strategic focus on expanding its minimally invasive care ecosystem, including its Ion endoluminal system, and its commitment to innovation and customer training are key drivers of its success. While facing macroeconomic headwinds such as inflation and higher interest rates, which have impacted customer capital spending, ISRG has managed its operations effectively, maintaining a solid cash position and continuing to invest in research and development to drive future growth. The company's extensive risk factor disclosures highlight the competitive landscape, regulatory environment, and supply chain challenges as areas of ongoing attention.